- Recce Pharmaceuticals (RCE) receives a grant of $50,000 through the Australian Government's Innovations Connections scheme
- The grant is the second of its kind received by RCE and will help assess its lead candidate in the Australian SARS-CoV-2 Antiviral Screening Program
- Led by the CSIRO, stage two of the program will study the efficacy of the therapy over several months, with testing set to start in September
- To date, RCE has received roughly $87,500 plus GST through the scheme
Read the Full Article on The Market Herald here
Recce Pharmaceuticals (ASX:RCE) accepts $50k grant for study with CSIRO
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
0.080(21.9%) |
Mkt cap ! $128.6M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 44.5¢ | 37.5¢ | $191.2K | 477.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12222 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 10976 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |